Breaking News

NASS News: FDA OKs Stryker's SpineJack Implantable Fracture Reduction System

SpineJack system is indicated for use in the reduction of painful osteoporotic vertebral compression fractures.

Related CONTENT

PR Newswire09.27.18

Stryker announced that it has received FDA 510(k) clearance to market the SpineJack Implantable Fracture Reduction System. The SpineJack system is indicated for use in the reduction of painful osteoporotic vertebral compression fractures.

In the SAKOS clinical study, the SpineJack system demonstrated superiority to balloon kyphoplasty (BKP) for the endpoints of freedom from adjacent level fracture and midline vertebral height restoration. The SpineJack system also showed substantial and sustained improvement in both pain (VAS) and function (Oswestry Disability Index) over BKP.

Available in three sizes to accommodate different vertebral body sizes, the SpineJack titanium implant is inserted and expanded, and PMMA bone cement is injected at low pressure to stabilize the restored vertebral body.

The SpineJack system has been commercially available in Europe since 2008 and over 70,000 units have been implanted worldwide. The company plans to execute a limited launch of the device for the remainder of 2018.

For more information, please visit Stryker's booth #1401 at the annual meeting of the North American Spine Society in Los Angeles September 26^th - 29^th.

Related Breaking News

Trauma/Sports

Dassiet Launches Lightweight Biodegradable Cast

UCAST splints are made of completely non-allergenic and non-toxic materials.
Dassiet 01.21.22
Ali Madani Invites Professionals to an Orthopedic Tutorial

The presentation will be held during the AAOS Annual meeting in Chicago in March.
Implants 01.20.22
Extremities

First Procedure for Stryker's Tornier Perform Patient-Matched Glenoid

First surgeon-driven, primary patient-specific implant available in shoulder arthroplasty.
Sam Brusco, Associate Editor 01.20.22
Biologics

Evonik and Samaplast Developing an Osteoconductive PEEK Biomaterial

Spinal cage prototype demonstrates design versatility.
Evonik 01.20.22
Imaging

Orthofix, nView Medical Begin Partnership and Investment Agreement

Will develop, co-market nView systems with Orthofix’s cervical spine and pediatric limb deformity correction tech.
Sam Brusco, Associate Editor 01.19.22
Spine/Neurology

Nevro's Senza SCS Label Expanded to Non-Surgical Refractory Back Pain

Makes it the only SCS system with a specific indication for NSRBP.
Sam Brusco, Associate Editor 01.19.22
Large Joint

Smith+Nephew Buys Engage Surgical for Up to $135M

Acquires the only commercially available cementless partial knee system in the U.S.
Sam Brusco, Associate Editor 01.19.22
Embody Appoints Rene Salas to Board and Expands Leadership Team

New additions bring significant strategic guidance, orthobiologic experience, and operational excellence to the company.
PR Newswire 01.19.22
Spine/Neurology

NIH Begins $9.8M Neuromodulation Competition

The first phase will award up to $800,000.
Sam Brusco, Associate Editor 01.18.22
Augmedics Appoints Kevin Hykes as President and CEO

Hykes is a 30-year medtech veteran.
Sam Brusco, Associate Editor 01.18.22
Spine/Neurology

NeuroMetrix's Quell Earns Breakthrough Status for CIPN

Chemotherapy-induced peripheral neuropathy (CIPN) affects about 30 percent of chemo patients.
Sam Brusco, Associate Editor 01.18.22
Imaging | Spine/Neurology

Surgalign's HOLO Portal AI-Driven, AR Spine Surgery Guidance System Earns FDA Nod

Creates patient-specific plan presented to the surgeon using the AR display.
Sam Brusco, Associate Editor 01.18.22
Imaging | Software & Quality | Spine/Neurology

FDA OK's VUZE Medical's VUZE System for Spine Surgery

Real-time image processing enables software-only guidance and verification.
Sam Brusco, Associate Editor 01.18.22
RecoveryOne Closes $33 Million Series C Financing

Company to use the money to scale its business and accelerate market expansion efforts.
PR Newswire 01.18.22
Large Joint

AAOS Updates Clinical Practice Guideline for Knee Osteoarthritis

Update offers the latest in evidence-based recommendations to help orthopedic surgeons and physicians determine best treatment approach.
American Academy of Orthpaedic Surgeons 01.17.22